To ensure that a patient's test is billed to their 2024 health benefits, testing must be started before the end of the year. For exome, genome, or Xpanded testing, if you do not expect parental samples to be received before the end of the year, please contact us at [email protected] to determine how to proceed.

Prenatal Whole Genome Chromosomal Microarray

New York
Approved

Conditions

  • Chromosomal Abnormalities
  • Uniparental Disomy

Clinical Utility

  • Abnormal fetal ultrasound findings
  • Ambiguous karyotype results
  • Suspected deletion/duplication syndrome
  • Family history of known or suspected chromosome imbalances
  • Abnormal maternal serum screening
  • Advanced maternal age

Lab Method

  • Whole Genome Chromosomal Microarray

Test Code

460

CPT Codes*

81229x1

ABN Required

No

Turnaround Time**

~2 weeks

Preferred Specimen

20 mL Amniotic Fluid

Alternative Specimen

20 mg CVS, 2 T25 flasks cultured amnioctyes, 2 T25 flasks of cultured chorionic villi, 3 ug DNA, POC or other fetal tissue

*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.

Need something else?

Search More Tests